NEO
NeoGenomics, Inc.
NeoGenomics is a clinical laboratory and genomics company with minimal direct government dependence and low political profile, primarily exposed to healthcare regulation and reimbursement policy.
Govt Dependence
35/100
Regulatory Density
65/100
Lobbying Intensity
5/100
Political Signal
LOW
BusinessWhat NEO does
NeoGenomics operates a network of CLIA-certified laboratories providing cancer genomics, hematologic malignancy testing, and other molecular diagnostic services. Revenue derives primarily from clinical laboratory testing reimbursed by insurance, Medicare/Medicaid, and out-of-pocket patients.
Executive Branch ConflictsNEO held by Trump-administration officials
1 cabinet/senior official reported NEO positions in OGE Form 278 disclosures across 7 filings.
Donald J. Trump
President · White House
NEOGENOMICS INC
Donald J. Trump
President · White House
NEOGENOMICS INC
Donald J. Trump
President · White House
NEOGENOMICS INC
Donald J. Trump
President · White House
NEOGENOMICS INC
Donald J. Trump
President · White House
NEOGENOMICS INC
Donald J. Trump
President · White House
NEOGENOMICS INC
Donald J. Trump
President · White House
NEOGENOMICS INC
Lifetime Government AwardsNEO federal contracts by year
$0
total awarded · 2013–2013
1
contracts on file
2013
peak year ($0)
Top contracts by award amount
$0K
Department of Veterans Affairs
2013-09-16
IGF::CL::IGF FISH STAINING TECH PORTION ONLY FOR BUFFALO VAMC.
1 years · 1 contracts
Smart Money · 13F HoldingsHedge funds holding NEO
$2.01B
Total NEO held by tracked 13F funds
4
Funds with NEO positions
+1
Funds opened this quarter
Renaissance Technologies
$1.89B
opened
2026-03-31
Millennium Management
$61M
-13%
2025-12-31
D.E. Shaw & Co.
$51M
+46%
2025-12-31
Citadel Advisors
$15M
-35%
2025-12-31
Politicians Trading NEOMembers of Congress with recent NEO positions
1 politicians traded NEO across 2 disclosed transactions totaling $16K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just NEO). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading NEO
2025-05-07
Gilbert Ray Cisneros
purchase
$1,001 - $15,000
2025-05-07
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2022-03-30
Dwight Evans
sale
$1,001 - $15,000
2022-03-30
Dwight Evans
Sale
$1,001 - $15,000
2021-12-30
Deborah K. Ross
purchase
$15,001 - $50,000
2021-12-30
Deborah K. Ross
Purchase
$15,001 - $50,000
2021-11-09
(unknown)
Sale
$1,001 - $15,000
2021-11-09
(unknown)
sale
$1,001 - $15,000
2020-03-02
Dwight Evans
purchase
$1,001 - $15,000
52d late
2020-03-02
Dwight Evans
Purchase
$1,001 - $15,000
52d late
2019-12-19
(unknown)
purchase
$1,001 - $15,000
2019-12-19
(unknown)
Purchase
$1,001 - $15,000
12+ trades on file · most recent 2025-06-06
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
Medicare reimbursement rate adjustmentsCLIA regulation updatesGenetic testing coverage policy
Political ProfileWhere NEO sits in Washington
NeoGenomics has minimal lobbying footprint, no named legislative wins/losses, and no measurable campaign engagement. Stock movement driven primarily by clinical trial data, reimbursement announcements, and M&A activity rather than political events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- CMS reimbursement rate cuts
- CLIA enforcement tightening
- genetic privacy regulation
Regulatory opportunities
- expanded Medicare coverage for genomic testing
- CLIA modernization
- hereditary cancer screening reimbursement
Member intelligence layer
Live signals + predictions for NEO — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades NEO
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout NEO & political exposure
Does NeoGenomics, Inc. (NEO) hold federal contracts?
Yes. NeoGenomics, Inc. has 1 federal contract awards totaling $0, primarily from agencies including Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own NEO stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in NEO on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded NEO stock?
12 congressional trades by 4 unique members of Congress, most recently on 2025-05-07. See the Congressional Trading panel for politician-by-politician breakdown.
What is NEO political risk profile?
Government dependence: 35/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track NEO political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. NEO data is updated daily from these official federal sources.